Session

08.09.2021     18:45–19:45

Title:
Poster Session 2
Type:
Poster Session

08.09.2021
18:45–19:45

Title:
Poster Session 2
Type:
Poster Session


18:45–18:48
P021 Co-occurring neck-pain in patients with episodic migraine and analgesic intake
A. Chernenko (Kharkiv/UA)
Talk time: 2 + 1 min


18:48–18:51
P022 Differences in sensory nucleus of the trigeminal nerve, dorso-lateral pons, and somatosensory cortex between migraine patients and healthy controls. An MRI post-processing study.
N. Morollón (Barcelona/ES)
Talk time: 2 + 1 min


18:51–18:54
P023 Nasopharyngeal Swab may Trigger Migraine by Peripheral Stimulation of Trigeminal Nerve
J. Madera Fernández (Santander/ES)
Talk time: 2 + 1 min


18:54–18:57
P024 Impact of COVID-19  lockdown in Argetinean patients with migraine
M. V. Nagel (Buenos Aires/AR)
Talk time: 2 + 1 min


18:57–19:00
P025 Hormonal changes as an aetiological factor in trigeminal neuralgia in women
S. Maarbjerg (Glostrup/DK)
Talk time: 2 + 1 min


19:00–19:03
P027 The neurological manifestations of COVID-19: a retrospective single-center clinical study in the Republic of Dagestan, Russia
Z. Gadzhieva (Makhachkala/RU)
Talk time: 2 + 1 min


19:03–19:06
P028 Genome-wide Analyses Identify the Genetic Landscape and Polygenic Risk Model of Reversible Cerebral Vasoconstriction Syndrome
S.-P. Chen (Taipei/TW)
Talk time: 2 + 1 min


19:06–19:09
P029 Impact of Lockdown during Covid-19 Pandemic in India on the Disease Activity and Quality of Life in migraine patients: A Web-Based Survey
D. Chowdhury (Delhi/IN)
Talk time: 2 + 1 min


19:09–19:12
P030 Hypermethylation of exon 1 of MTDH/AEG1 is associated with chronic migraine. A case-control study with GWAS-discovered migraine genes.
S. Pérez-Pereda (Santander/ES)
Talk time: 2 + 1 min


19:12–19:15
P031 White matter microstructural alterations in patients with persistent headache after COVID-19 infection: an exploratory study
Á. Planchuelo-Gómez (Valladolid/ES)
Talk time: 2 + 1 min


19:15–19:18
P032 Evaluation of Headache Caused by the Use of Protective Equipment in Hospital Personnel during COVID-19 Pandemic  
E. Jafari (Tehran/IR)
Talk time: 2 + 1 min


19:18–19:21
P033 Headache during the COVID- 19 first wave: a survey on admissions' frequency, diagnosis and management in Emergency Department.
L. D'Acunto (Trieste/IT)
Talk time: 2 + 1 min


19:21–19:24
P034 Clinical characteristics of headache after vaccination against COVID-19 (Coronavirus SARS-CoV-2) with the BNT162b2 mRNA vaccine: a prospective multicentre observational cohort study
C. Göbel (Lübeck/DE)
Talk time: 2 + 1 min


19:24–19:27
P035 Resting-state functional alterations in patients with persistent headache after COVID-19 infection: an exploratory study
Á. Planchuelo-Gómez (Valladolid/ES)
Talk time: 2 + 1 min


19:27–19:30
P036 Facemask headache: a new nosographic entity among healthcare professionals in COVID-19 era
L. Rapisarda (Catanzaro/IT), M. Trimboli (Catanzaro/IT)
Talk time: 2 + 1 min


19:30–19:33
P038 A novel ATP1A2 gene variant associated with sporadic hemiplegic migraine
M. Trimboli (Catanzaro/IT)
Talk time: 2 + 1 min


19:33–19:36
P039 Clinical predictors of persistent post-COVID-19 headache
D. García-Azorín (Valladolid/ES)
Talk time: 2 + 1 min


19:36–19:39
P040 Persistence of headache post-COVID-19: A multicentric prospective study of 9-months follow-up
D. García-Azorín (Valladolid/ES)
Talk time: 2 + 1 min


19:39–19:42
P041 Clinical characteristics of headache after vaccination against COVID-19 (Coronavirus SARS-CoV-2) with the COVID-19 Vaccine AstraZeneca: a prospective multicentre observational cohort study
C. Göbel (Lübeck/DE)
Talk time: 2 + 1 min


19:42–19:45
P042 Impact of personal protective equipment use in migraine patients during the COVID-19 pandemic
R. Oliveira (Lisbon/PT)
Talk time: 2 + 1 min